Churchill Downs enters the final stretch before its October 28 earnings print with short sellers building positions at their fastest weekly pace in months, even as the stock slides to its lowest levels since early summer.
The most striking move this week is the speed of short-side accumulation. Short interest jumped 17% in a single week to 6.3% of the float — roughly 4.37 million shares — the steepest seven-day rise in the 30-day window tracked here. That move sits against a stock already down 11% over the past month and 6% on the week alone, closing at $80.60. The short score has crept up five consecutive sessions, now at 46.3, up from 41.8 two weeks ago. That's not yet at extreme levels, but the direction is clear and consistent. What makes the setup less combustible than the headline suggests is the lending market: availability is ample at roughly 1,138% — meaning there are more than eleven shares available to borrow for every one already lent out — and cost to borrow is a negligible 0.43%. Shorts are rebuilding without facing any friction in the borrow pool. The borrow availability has tightened noticeably all month (it was above 2,000% in late August), but remains well within the loose-to-normal range.
Options positioning adds another layer to the caution. The put/call ratio is running at 8.06, well above the 52-week low of 0.14 and close to the elevated mid-September range — though it has actually eased slightly from peaks above 9 seen in late August. The 20-day mean is 7.62, so the ratio is only marginally elevated on a z-score basis (0.26), suggesting this level of put-heavy positioning has become the new baseline for CHDN options traders over the past several weeks. The abrupt shift from sub-5 PCR readings before August 21 to consistently above 7.6 thereafter is the more telling structural change. Something shifted in late August that made options traders broadly more defensive, and that posture has not reversed.
The Street remains constructive but is losing conviction on price. The consensus is still a buy, with nine firms positive, and the mean price target of ~$130 implies meaningful upside from current levels — though that gap has widened sharply as the stock has fallen. The most recent action, Wolfe Research initiating at Outperform with a $119 target in early September, was the only fresh coverage in the window. Around the July 30 earnings print, the response was mixed: Wells Fargo and Citizens both trimmed targets while keeping positive ratings, while Mizuho nudged its target slightly higher to $157. The wide dispersion in targets — from $117 to $157 — reflects genuine disagreement about where earnings power lands once the Kentucky Derby seasonality normalises. The bull case rests on 25% EBITDA growth in the Live and Historical Racing segment and the momentum behind Historical Racing Machines in Virginia and Kentucky. Bears point to flat Gaming segment EBITDA and weak price momentum; the short score rank at the 35th percentile and EPS momentum scores in the low-to-mid 40s support that softer view on near-term catalysts.
The earnings history provides a sobering backdrop. The last two quarterly prints each produced next-day declines of roughly 4.8% and 7.3%, with five-day drawdowns of 1.9% and 3.1% respectively. Both were negative outcomes. That pattern, combined with a stock already under meaningful pressure heading into October, means the next question for traders is less about whether the Derby franchise is structurally strong — it is — and more about whether Q3 gaming and HRM figures can arrest the momentum that has formed around the short side.
PENN gained 4.7% on the week while DKNG added 3.2%, making CHDN's 6% decline look distinctly idiosyncratic rather than sector-driven. Whether that divergence narrows as October's print approaches is the number to watch.
See the live data behind this article on ORTEX.
Open CHDN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
